Wei Lemaire

2.3k citations

25 papers · 1.2k · h-index 16

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
Biological Psychiatry top 5%

Papers in

Molecular Biology 14
- Receptor Mechanisms and Signaling 7
- Pharmacological Receptor Mechanisms and Effects 4
Cellular and Molecular Neuroscience 12
- Neuroscience and Neuropharmacology Research 10

Co-authors: Cyrille Sur (13 shared papers)P. Jeffrey Conn (8 shared papers)David L. Williams (13 shared papers)Craig W. Lindsley (11 shared papers)Julie A. O’Brien (10 shared papers)Douglas J. Pettibone (8 shared papers)Marlene A. Jacobson (9 shared papers)Maryann Burno (5 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)SLAS DISCOVERY (1 paper)ACS Medicinal Chemistry Letters (1 paper)Journal of Neuroscience (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

Wei Lemaire

25 papers receiving 1.2k citations

Peers

Countries citing papers authored by Wei Lemaire

Since Specialization

Citations

This map shows the geographic impact of Wei Lemaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lemaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lemaire more than expected).

Fields of papers citing papers by Wei Lemaire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lemaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lemaire. The network helps show where Wei Lemaire may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Lemaire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Lemaire Line = papers co-authored together Wei Lemaire links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models Journal of Pharmacology and Experimental Therapeutics ·Gene G. Kinney, Julie A. O’Brien, Wei Lemaire, Maryann Burno, Denise Bickel, Michelle K. Clements, Tsing‐Bau Chen, David D. Wisnoski, Craig W. Lindsley, Philip R. Tiller, Sheri Smith, Marlene A. Jacobson, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	2005	229
2	A Family of Highly Selective Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 Molecular Pharmacology ·Julie A. O’Brien, Wei Lemaire, Tsing‐Bau Chen, Raymond S.L. Chang, Marlene A. Jacobson, Sookhee Ha, Craig W. Lindsley, Hervé Schaffhauser, Cyrille Sur, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	2003	170
3	The Glycine Transporter Type 1 InhibitorN-[3-(4′-Fluorophenyl)-3-(4′-Phenylphenoxy)Propyl]Sarcosine Potentiates NMDA Receptor-Mediated ResponsesIn Vivoand Produces an Antipsychotic Profile in Rodent Behavior Journal of Neuroscience ·Gene G. Kinney, Cyrille Sur, Maryann Burno, Pierre Mallorga, Jacinta B. Williams, David J. Figueroa, Marion Wittmann, Wei Lemaire, P. Jeffrey Conn	2003	147
4	Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of N-(1,3-Diphenyl-1H- pyrazol-5-yl)benzamides That Potentiate Receptor Function in Vivo Journal of Medicinal Chemistry ·Craig W. Lindsley, David D. Wisnoski, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Maryann Burno, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Mark E. Duggan, George D. Hartman, P. Jeffrey Conn, Joel R. Huff	2004	139
5	A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain Journal of Pharmacology and Experimental Therapeutics ·Julie A. O’Brien, Wei Lemaire, Marion Wittmann, Marlene A. Jacobson, Sookhee Ha, David D. Wisnoski, Craig W. Lindsley, Hervé Schaffhauser, Blake A. Rowe, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	2004	132
6	Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, David D. Wisnoski, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Marion Wittman, Sookhee Ha, Hervé Schaffhauser, Cyrille Sur, D. J. PETTIBONE, Mark E. Duggan, P. Jeffrey Conn, George D. Hartman, Craig W. Lindsley	2006	58
7	Proline bis-amides as potent dual orexin receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman, Anthony J. Roecker, Swati P. Mercer, Rodney A. Bednar, Duane R. Reiss, Richard W. Ransom, C. Meacham Harrell, Douglas J. Pettibone, Wei Lemaire, Kathy Murphy, Chunze Li, Thomayant Prueksaritanont, Christopher J. Winrow, John J. Renger, Kenneth S. Koblan, George D. Hartman, Paul J. Coleman	2008	54
8	Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy Bioorganic & Medicinal Chemistry Letters ·B. Wesley Trotter, Kausik K. Nanda, Christopher S. Burgey, Craig M. Potteiger, James Z. Deng, Ahren I. Green, John C. Hartnett, Nathan R. Kett, Zhicai Wu, Darrell A. Henze, Kimberly Della Penna, Reshma R. Desai, Michael Leitl, Wei Lemaire, Rebecca B. White, Suzie Yeh, Mark O. Urban, Stefanie A. Kane, George D. Hartman, Mark T. Bilodeau	2011	50
9	Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides ChemMedChem ·Craig W. Lindsley, Zhijian Zhao, William Leister, Julie L. O'Brien, Wei Lemaire, David L. Williams, Tsing‐Bau Chen, Raymond S.L. Chang, Maryann Burno, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, Douglas J. Pettibone, Philip R. Tiller, Sheri Smith, Nancy N. Tsou, Mark E. Duggan, P. Jeffrey Conn, George D. Hartman	2006	32
10	A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies Nuclear Medicine and Biology ·Zhizhen Zeng, Julie A. O’Brien, Wei Lemaire, Stacey O’Malley, Patricia Miller, Zhijian Zhao, Michael A. Wallace, Conrad E. Raab, Craig W. Lindsley, Cyrille Sur, David L. Williams	2008	23
11	Benzimidazole CB2 agonists: Design, synthesis and SAR Bioorganic & Medicinal Chemistry Letters ·Kausik K. Nanda, Darrell A. Henze, Kimberly Della Penna, Reshma R. Desai, Michael Leitl, Wei Lemaire, Rebecca B. White, Suzie Yeh, Janine N. Brouillette, George D. Hartman, Mark T. Bilodeau, B. Wesley Trotter	2013	22
12	Development of a scintillation proximity assay for analysis of Na+/Cl−-dependent neurotransmitter transporter activity Analytical Biochemistry ·Jacinta B. Williams, Pierre Mallorga, Wei Lemaire, David L. Williams, Na Sang, Smita S. Patel, Jeffrey Conn, Douglas J. Pettibone, Christopher Austin, Cyrille Sur	2003	21
13	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) Bioorganic & Medicinal Chemistry Letters ·Swati P. Mercer, Anthony J. Roecker, Susan L. Garson, Duane R. Reiss, C. Meacham Harrell, Kathy Murphy, Joseph G. Bruno, Rodney A. Bednar, Wei Lemaire, Donghui Cui, Tamara D. Cabalu, Cuyue Tang, Thomayant Prueksaritanont, George D. Hartman, Steven D. Young, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2013	19
14	Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant Bioorganic & Medicinal Chemistry Letters ·Izzat T. Raheem, Michael J. Breslin, Joseph G. Bruno, Tamara D. Cabalu, Andrew Cooke, Christopher D. Cox, Donghui Cui, Susan L. Garson, Anthony L. Gotter, Steven V. Fox, C. Meacham Harrell, Scott D. Kuduk, Wei Lemaire, Thomayant Prueksaritanont, John J. Renger, Craig A. Stump, Pamela L. Tannenbaum, Peter D. Williams, Christopher J. Winrow, Paul J. Coleman	2014	17
15	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, Julie A. O’Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, George D. Hartman, Craig W. Lindsley, S. E. Wolkenberg	2009	16
16	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg, Zhijian Zhao, David D. Wisnoski, William Leister, Julie L. O'Brien, Wei Lemaire, David L. Williams, Marlene A. Jacobson, Cyrille Sur, Gene G. Kinney, D. J. PETTIBONE, Philip R. Tiller, Sheri Smith, Christopher R. Gibson, Bennett Ma, Stacey L. Polsky-Fisher, Craig W. Lindsley, George D. Hartman	2009	15
17	Decahydroquinoline amides as highly selective CB2 agonists: Role of selectivity on in vivo efficacy in a rodent model of analgesia Bioorganic & Medicinal Chemistry Letters ·Peter J. Manley, Amy E. Zartman, Daniel V. Paone, Christopher S. Burgey, Darrell A. Henze, Kimberly Della Penna, Reshma R. Desai, Michael Leitl, Wei Lemaire, Rebecca B. White, Suzie Yeh, Mark O. Urban, Stefanie A. Kane, George D. Hartman, Mark T. Bilodeau, B. Wesley Trotter	2011	15
18	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, Kevin F. Gilbert, Scott D. Kuduk, C. Meacham Harrell, Susan L. Garson, Steven V. Fox, Anthony L. Gotter, Pamela L. Tannenbaum, Thomayant Prueksaritanont, Tamara D. Cabalu, Donghui Cui, Wei Lemaire, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2015	14
19	A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy Neurobiology of Disease ·Mali Cosden, Sarah Jinn, Lihang Yao, Cheryl A. Gretzula, Monika Kandebo, Dawn Toolan, Nathan G. Hatcher, Lei Ma, Wei Lemaire, Gregory C. Adam, Christine Burlein, Christina Minnick, Rose Flick, Marla L. Watt, James Mulhearn, Mark E. Fraley, Robert E. Drolet, Jacob Marcus, Sean M. Smith	2021	14
20	Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction ACS Medicinal Chemistry Letters ·Douglas C. Beshore, Gregory C. Adam, Richard J. O. Barnard, Christine Burlein, Steven N. Gallicchio, M. Katharine Holloway, Daniel J. Krosky, Wei Lemaire, Robert W. Myers, Sangita B. Patel, Michael A. Plotkin, David Powell, Vanessa Rada, Christopher D. Cox, Paul J. Coleman, Daniel J. Klein, S. E. Wolkenberg	2021	14

About Wei Lemaire

Wei Lemaire is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Biochemistry, Cognitive Neuroscience and Experimental and Cognitive Psychology, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Receptor Mechanisms and Signaling (7 papers), Amino Acid Enzymes and Metabolism (6 papers), Sleep and related disorders (5 papers), Sleep and Wakefulness Research (5 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Circadian rhythm and melatonin (3 papers) and Photochromic and Fluorescence Chemistry (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (881 citations), Biological Psychiatry (73 citations), Biochemistry (148 citations), Toxicology (49 citations) and Endocrine and Autonomic Systems (96 citations). Wei Lemaire has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Cyrille Sur, P. Jeffrey Conn, David L. Williams, Craig W. Lindsley, Julie A. O’Brien, Douglas J. Pettibone, Marlene A. Jacobson, Maryann Burno, Gene G. Kinney and Mark E. Duggan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, SLAS DISCOVERY, ACS Medicinal Chemistry Letters and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Wei Lemaire

Impact in

Papers in i

In The Last Decade

Wei Lemaire

Peers

Countries citing papers authored by Wei Lemaire

Fields of papers citing papers by Wei Lemaire

All Works

About Wei Lemaire

Explore authors with similar magnitude of impact

Papers in